Szerző: " Lin Hugh"

Wong Tien Y.; Haskova Zdenka; Asik Kemal; Baumal Caroline R.; Csaky Karl G.; Eter Nicole; Ives Jane A.; Jaffe Glenn J.; Korobelnik Jean-François; Lin Hugh; Murata Toshinori; Ruamviboonsuk Paisan; Schlottmann Patricio G.; Seres András I.; Silverman David; Sun Xiaodong; Tang Yannan; Wells John A.; Hee Yoon Young; Wykoff Charles C.; Kollaborációs szervezet: YOSEMITE and RHINE Investigators; NEM RÉSZLETEZETT; Papp András; Tóth-Molnár Edit: Faricimab Treat-and-Extend for Diabetic Macular Edema: Two-Year Results from the Randomized Phase 3 YOSEMITE and RHINE Trials.
OPHTHALMOLOGY, 131 (6). pp. 708-723. ISSN 0161-6420 (2024)

Heier Jeffrey S.; Khanani Arshad M.; Ruiz Carlos Quezada; Basu Karen; Ferrone Philip J.; Brittain Christopher; Figueroa Marta S.; Lin Hugh; Holz Frank G.; Patel Vaibhavi; Lai Timothy Y. Y.; Silverman David; Tóth-Molnár Edit; Zatorska Barbara; Kollaborációs szervezet: TENAYA and LUCERNE Investigators: Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials.
LANCET, 399 (10326). pp. 729-740. ISSN 0140-6736 (2022)

Wykoff Charles C.; Abreu Francis; Adamis Anthony P.; Basu Karen; Eichenbaum David A.; Haskova Zdenka; Lin Hugh; Loewenstein Anat; Mohan Shaun; Pearce Ian A.; Sakamoto Taiji; Schlottmann Patricio G.; Papp András; Tóth-Molnár Edit; Kollaborációs szervezet: YOSEMITE and RHINE Investigators: Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials.
LANCET, 399 (10326). pp. 741-755. ISSN 0140-6736 (2022)